ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01968772
Recruitment Status : Completed
First Posted : October 24, 2013
Last Update Posted : December 24, 2014
Sponsor:
Collaborator:
Magnesium Direct
Information provided by (Responsible Party):
Dietlind Wahner-Roedler, Mayo Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2014
  Actual Study Completion Date : September 2014
Publications:
Ali M, Ali O. Fibromyalgia: An oxidative-dysoxygenative disorder (ODD). J Integr Med. 1999;3:17-37.
London M. The role of magnesium in fibromyalgia. 1994. http://web.mit.edu/london/www.magnesium.html
Clauw D, Ward K, Katz P, Rajan S. Muscle intracellular magnesium levels with pain tolerance in fibromyalgia (FM). Arthritis Rheumat. 1994;S213:324.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):